Bluschke, Annet
Broschwitz, Felicia
Kohl, Simon
Roessner, Veit
Beste, Christian
Article History
Received: 20 April 2016
Accepted: 13 July 2016
First Online: 12 August 2016
Competing interests
: A. Bluschke, F. Broschwitz and S. Kohl declare no competing or potential conflicts of interest. V. Roessner has received payment for consulting and writing activities from Lilly, Novartis and Shire Pharmaceuticals, lecture honoraria from Lilly, Novartis, Shire Pharmaceuticals and Medice Pharma and support for research from Shire and Novartis. He has carried out (and is currently carrying out) clinical trials in cooperation with the Novartis, Shire and Otsuka companies. C. Beste has received payment for consulting from GlaxoSmithKline and Teva.